Why Transcode Therapeutics (RNAZ) Stock Is Moving
Why Transcode Therapeutics (RNAZ) Stock Is Moving
The effective date of the reverse split will be announced at least two business days in advance.Transcode Therapeutics Inc (NASDAQ:RNAZ) shares are trading lower by 9% to 34 cents Monday afternoon after the company announced its Board's approval of a 1-for-33 reverse stock split, aiming to boost its share price and maintain compliance with Nasdaq's minimum bid price requirements.
週一下午，Transcode Therapeutics Inc（納斯達克股票代碼：RNAZ）股價下跌9％，至34美分，此前該公司宣佈董事會批准了1比33的反向股票拆分，旨在提高其股價並保持對納斯達克最低出價要求的遵守。
What Else: Approved by stockholders on November 22, the split consolidates every 33 shares into one, reducing the outstanding shares from approximately 17.3 million to 523,202.
還有什麼：11月22日經股東批准，拆分將每33股合併爲一股，將已發行股票從約1730萬股減少到523,202股。
Fractional shares resulting from the split will be rounded up to the nearest whole share. Adjustments will also apply to the exercise prices of stock options, warrants, and shares under the company's incentive plans.
拆分產生的部分份額將四捨五入至最接近的整數。調整還將適用於公司激勵計劃下股票期權、認股權證和股票的行使價。
The effective date of the reverse split will be announced at least two business days in advance.
反向拆分的生效日期將至少提前兩個工作日公佈。
Read Also: 'Pharma Bro' Martin Shkreli Tells Investors To 'Short SAVA,' Stock Falls Over 80% After Phase 3 Update
另請閱讀：「製藥兄弟」 馬丁·什克雷利告訴投資者 「做空SAVA」，第三階段更新後股價下跌80％以上
According to data from Benzinga Pro, RNAZ has a 52-week high of $18.48 and a 52-week low of $0.22.
根據Benzinga Pro的數據，RNAZ的52周高點爲18.48美元，52周低點爲0.22美元。
